ALIROCUMAB EFFECTIVENESS AND RAPIDITY IN ACHIEVING AND MAINTAINING TARGET LDL CHOLESTEROL VALUES IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK, ALSO ASSESSING ITS EFFECTS ON TRIGLYCERIDE AND HDL CHOLESTEROL VALUES
Anno:
2023
Introduction:Still too few patients (pts)after an acute cardiocerebrovascular(CeVD) event reach LDL-C values recommended by guidelines even in therapy with statins and Ezetimibe(Eze),thus maintaining a high risk of new cardiovascular(CV)episodesPurpose: To evaluate in a long follow-up the effectiveness and the rapidity of Alirocumab(Ali)in the attainment and maintenance of LD-C target…